Vector Borne News Today

Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") contributed to the development of a pediatric formulation to treat schistosomiasis as a member of the Pediatric Praziquantel Consortium (Consortium). The Consortium announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive scientific opinion for arpraziquantel to treat one of the neglected tropical diseases, schistosomiasis, in preschoo...

The suspicious letters were sent to vote centers and government buildings in six states this month.

By Stephen Nakrosis The Food and Drug Administration said it granted approval of Ixchiq, the first vaccine for chikungunya virus, to Valneva Austria. Valneva...

DIMAPUR — To review the activities undertaken to prevent the spread of dengue as well as discuss measures to be adopted to tackle the rising cases in

DIMAPUR, NOVEMBER 3 (MExN): A meeting of the State Task Force Team (STF) on Vector Borne and Other Communicable Diseases was convened by V Kezo, Commissioner & Secretary, H&FW on November 3 at the Conference Hall of Health & Family Welfare Department, Nag

“There is this ‘Smart City’ intervention because of which there is a lot of civil construction…”

By Denny Jacob Takeda Pharmaceutical's vaccine to prevent dengue, qdenga, was recommended by a World Health Organization advisory group. The company, which...

Shares of T2 Biosystems extended their losing streak to two days Wednesday.

Ranchi: Amid concern over the rising cases of vector-borne diseases, the health department formed separate teams to inspect households across the stat.

By Cecilia Butini Valneva has received positive safety data in a Phase 3 trial studying a vaccine against the mosquito-borne chikungunya virus. Data showed...